...
首页> 外文期刊>Current diabetes reviews >Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
【24h】

Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management

机译:胰岛素致死:糖尿病管理中自残和自杀的管理

获取原文
获取原文并翻译 | 示例

摘要

Suicide is the tenth leading cause of death in Americans of all ages. Presence of a chronic medical illness {e.g. Diabetes mellitus) increases the risk of suicide. The goal of this review is to examine the relationship between diabetes and depression, as well as diabetes and suicide. Earlier this year, the U.S. Preventive Task Force (USPTF) escalated their recommendation for depression to include not only routine screening for depression but additional focus on active follow up that requires measurement based care. As a result, it is important that persons with diabetes are also screened for suicidal ideation in the presence of a mood disorder. Due to the higher risk and access to potentially lethal medications in persons with diabetes, risk mitigation procedures should be in place that includes not only depression and suicide screening but also the use of inter-disciplinary teams. Appropriate medical monitoring is essential following a suicide attempt to avoid death particularly because these patients are prone to repeat attempts.
机译:自杀是所有年龄段美国人的第十大死因。存在慢性躯体疾病(例如糖尿病)会增加自杀的风险。本综述的目的是研究糖尿病与抑郁症以及糖尿病与自杀之间的关系。今年早些时候,美国预防工作组(USPTF)升级了他们对抑郁症的建议,不仅包括抑郁症的常规筛查,还包括对需要基于测量的护理的积极随访的额外关注。因此,重要的是,在存在心境障碍的情况下,对糖尿病患者进行自杀意念筛查。由于糖尿病患者的风险较高,并且获得潜在致命药物的机会较高,因此应制定风险缓解程序,不仅包括抑郁症和自杀筛查,还包括使用跨学科团队。在自杀未遂后,适当的医疗监测对于避免死亡至关重要,特别是因为这些患者容易重复尝试。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号